Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence and Food Effect Study of Evacetrapib Single Tablet vs Two Tablets in Healthy Japanese Subjects
jRCT2080222624Phase 1
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of evacetrapib in hyperlipidemia (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Primary pharmacokinetic endpoints.
02
Drugs
evacetrapib
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on jRCT2080222624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222624.